PEDF as a treatment for cervical cancer

Cancer Biol Ther. 2010 Jun 15;9(12):975-7. doi: 10.4161/cbt.9.12.11985. Epub 2010 Jun 5.

Authors

Anne R Murray¹, Jian-xing Ma

Affiliation

¹ Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

PMID: 20424516
DOI: 10.4161/cbt.9.12.11985

No abstract available

Publication types

Comment

MeSH terms

Angiogenesis Inhibitors / pharmacology
Angiogenesis Inhibitors / therapeutic use*
Eye Proteins / pharmacology
Eye Proteins / therapeutic use*
Female
Humans
Hypoxia-Inducible Factor 1, alpha Subunit / metabolism
Neovascularization, Pathologic / drug therapy*
Nerve Growth Factors / pharmacology
Nerve Growth Factors / therapeutic use*
Serpins / pharmacology
Serpins / therapeutic use*
Tumor Burden / drug effects
Uterine Cervical Neoplasms / blood supply
Uterine Cervical Neoplasms / drug therapy*
Uterine Cervical Neoplasms / metabolism
Uterine Cervical Neoplasms / pathology
Vascular Endothelial Growth Factor A / metabolism

Substances

Angiogenesis Inhibitors
Eye Proteins
Hypoxia-Inducible Factor 1, alpha Subunit
Nerve Growth Factors
Serpins
Vascular Endothelial Growth Factor A
pigment epithelium-derived factor